OptimizeRx: Q4 Earnings Report Indicates Caution For 2026 (NASDAQ:OPRX)

Core Viewpoint - OptimizeRx (OPRX) has experienced a significant decline in stock price, dropping from the $20s to single digits, largely attributed to the AI-fear trade [1] Company Performance - The stock's recent performance reflects broader market trends affecting growth and momentum stocks, which are perceived as reasonably priced yet likely to outperform in the long term [1] Investment Strategy - The focus is on investing in high-quality growth stocks, with a historical reference to the S&P 500 increasing by 367% and the Nasdaq by 685% from 2009 to 2019, indicating potential for long-term gains [1]